Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.
- ISBN10 6611231749
- ISBN13 9786611231743
- Publish Date 1 January 2008
- Publish Status Active
- Out of Print 9 February 2012
- Publish Country US
- Imprint Springer
- Format eBook
- Pages 194
- Language English